Dysfunctional gene/protein networks in hepatitis C virus-induced hepatocellular cirrhosis and carcinoma

2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010

Volumn , Issue , 2010, Pages 502-507

  Huang, Tao ^a,b   Ding, Guohui ^a,b   Li, Yixue ^a,b   Liu, Lei ^a,b   Tan, Eugene ^c   Dai, Hongyue ^c   Liu, Qi ^a   Tu, Zhidong ^c   Xie, Lu ^a  

^a SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^b Chinese Academy of Sciences   (China)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENES; CARCINOGENIC EFFECTS; DIFFERENTIAL EXPRESSIONS; GENE EXPRESSION PROFILES; HEPATITIS C VIRUS; HEPATOCELLULAR; HEPATOCELLULAR CARCINOMA; JAK/STAT; LIVER TISSUE; MOLECULAR MECHANISM; NUCLEAR FACTORS; P-VALUES; PROTEIN CORE; RISK FACTORS; TRANSITION STATE; TUMORIGENESIS;

COMPUTER VIRUSES; GENE EXPRESSION; LIVER; VIRUSES;

BIOINFORMATICS;

EID: 77958024537     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/1854776.1854873     Document Type: Conference Paper

References (30)

1. H. B. El-Serag, and A. C. Mason, "Rising incidence of hepatocellular carcinoma in the United States," N Engl J Med, vol. 340, no. 10, pp. 745-50, Mar 11, 1999.
2. A. Tagger, F. Donato, M. L. Ribero et al., "Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study," Int J Cancer, vol. 81, no. 5, pp. 695-9, May 31, 1999.
3. H. Tsukuma, T. Hiyama, S. Tanaka et al., "Risk factors for hepatocellular carcinoma among patients with chronic liver disease," N Engl J Med, vol. 328, no. 25, pp. 1797-801, Jun 24, 1993. (Pubitemid 23174709)
4. N. Appel, T. Schaller, F. Penin et al., "From structure to function: new insights into hepatitis C virus RNA replication," J Biol Chem, vol. 281, no. 15, pp. 9833-6, Apr 14, 2006.
5. B. Bartosch, R. Thimme, H. E. Blum et al., "Hepatitis C virus-induced hepatocarcinogenesis," J Hepatol, vol. 51, no. 4, pp. 810-20, Oct, 2009.
6. "Comprehensive genomic characterization defines human glioblastoma genes and core pathways," Nature, vol. 455, no. 7216, pp. 1061-8, Oct 23, 2008.
7. D. Jones, "Pathways to cancer therapy," Nat Rev Drug Discov, vol. 7, no. 11, pp. 875-876, 2008.
8. S. Jones, "Core signaling pathways in human pancreatic cancers revealed by global genomic analyses," Science, vol. 321, pp. 1801-1806, 2008.
9. D. Williams Parsons, "An integrated genomic analysis of human glioblastoma multiforme," Science, vol. 321, pp. 1807-1812, 2008.
10. Q. Cui, Y. Ma, M. Jaramillo et al., "A map of human cancer signaling," Mol Syst Biol, vol. 3, pp. 152, 2007.
11. V. R. Mas, D. G. Maluf, K. J. Archer et al., "Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma," Mol Med, vol. 15, no. 3-4, pp. 85-94, Mar-Apr, 2009.
12. B. de Chassey, V. Navratil, L. Tafforeau et al., "Hepatitis C virus infection protein network," Mol Syst Biol, vol. 4, pp. 230, 2008.
13. L. J. Jensen, M. Kuhn, M. Stark et al., "STRING 8--a global view on proteins and their functional interactions in 630 organisms," Nucleic Acids Res, vol. 37, no. Database issue, pp. D412-6, Jan, 2009.
14. Y. Qi, and H. Ge, "Modularity and dynamics of cellular networks," PLoS Comput Biol, vol. 2, no. 12, pp. e174, Dec 29, 2006.
15. R. A. Fisher, "Combining independent tests of significance," American Statistician, vol. 2, no. 5, pp. 30, 1948.
16. Z.-P. Liu, Y. Wang, T. Wen et al., "Dynamically dysfunctional protein interactions in the development of Alzheimer's disease," in IEEE International Conference on Systems, Man, and Cybernetics, San Antonio, Texas, USA, 2009.
17. D. Hwang, A. G. Rust, S. Ramsey et al., "A data integration methodology for systems biology," Proc Natl Acad Sci U S A, vol. 102, no. 48, pp. 17296-301, Nov 29, 2005.
18. H. Y. Chang, D. S. Nuyten, J. B. Sneddon et al., "Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival," Proc Natl Acad Sci U S A, vol. 102, no. 10, pp. 3738-43, Mar 8, 2005.
19. B. Boldajipour, H. Mahabaleshwar, E. Kardash et al., "Control of chemokine-guided cell migration by ligand sequestration," Cell, vol. 132, no. 3, pp. 463-73, Feb 8, 2008.
20. H. Ishizaki, A. Togawa, M. Tanaka-Okamoto et al., "Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors alpha and beta," J Immunol, vol. 177, no. 12, pp. 8512-21, Dec 15, 2006.
21. Y. Hoshida, A. Villanueva, M. Kobayashi et al., "Gene expression in fixed tissues and outcome in hepatocellular carcinoma," N Engl J Med, vol. 359, no. 19, pp. 1995-2004, Nov 6, 2008.
22. A. Macdonald, and M. Harris, "Hepatitis C virus NS5A: tales of a promiscuous protein," J Gen Virol, vol. 85, no. Pt 9, pp. 2485-502, Sep, 2004.
23. K. Moriya, H. Fujie, Y. Shintani et al., "The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice," Nat Med, vol. 4, no. 9, pp. 1065-7, Sep, 1998.
24. Y. Sato, J. Kato, R. Takimoto et al., "Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB," Gut, vol. 55, no. 12, pp. 1801-8, Dec, 2006.
25. C. P. Berg, S. F. Schlosser, D. K. Neukirchen et al., "Hepatitis C virus core protein induces apoptosis-like caspase independent cell death," Virol J, vol. 6, pp. 213, 2009.
26. K. Moriya, H. Yotsuyanagi, Y. Shintani et al., "Hepatitis C virus core protein induces hepatic steatosis in transgenic mice," J Gen Virol, vol. 78 ( Pt 7), pp. 1527-31, Jul, 1997.
27. L. E. Adinolfi, E. Durante-Mangoni, R. Zampino et al., "Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications," Aliment Pharmacol Ther, vol. 22 Suppl 2, pp. 52-5, Nov, 2005.
28. M. Romero-Gomez, "Insulin resistance and hepatitis C," World J Gastroenterol, vol. 12, no. 44, pp. 7075-80, Nov 28, 2006.
29. Z. L. Xiang, Z. C. Zeng, Z. Y. Tang et al., "Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival," BMC Cancer, vol. 9, pp. 176, 2009.
30. H. Liu, Z. Pan, A. Li et al., "Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells," Cell Mol Immunol, vol. 5, no. 5, pp. 373-8, Oct, 2008.